Surgical treatment of primary small-cell esophageal carcinoma.
- Author:
Ke-Lin SUN
1
;
Li-Xun CHAI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Carcinoma, Small Cell; drug therapy; mortality; surgery; Combined Modality Therapy; Esophageal Neoplasms; drug therapy; mortality; surgery; Female; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate
- From: Acta Academiae Medicinae Sinicae 2006;28(3):329-331
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the surgical treatment of primary small-cell esophageal carcinoma (PSEC).
METHODSWe retrospectively analyzed the clinical data of 73 patients with PSEC who received surgical treatment in our hospital from 1984 to 2003.
RESULTSThe overall resection rate was 94.5%. The complete resection rate was 89.0% and operation mortality was 1.4%. The 1-year, 3-year, and 5-year survival were 50.7%, 13.7%, and 8.2%, respectively.
CONCLUSIONSPSEC is a rare malignant tumor with poor prognosis. Surgical resection is the main method for patients in stage I or II, and postoperative chemotherapy seems to be helpful. Patients in stage Ill or IV should be managed with chemotherapy and radiotherapy.
